BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs4950928
,
SNCA
,
Apoptosis
,
HIV infection
,
Hypothalamus
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin 1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skin
Peritoneum
Fallopian tube
Liver
Fetal liver
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Congenital anomaly of integument
Alopecia
Musculoskeletal function
Aspergillosis
Malignant tumor of intestine
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
KDELR1 protein, human
BODIPY
Lymphotoxin-beta
17-hydroxyandrostane-3-glucuronide
GW8510
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NISCH
TRPC6
PAEP
LCP2
SCYL1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Autosomal recessive congenital ichthyosis caused by a pathogenic missense variant in CLDN1.
TNF-α induces Claudin-1 expression in renal tubules in Alport mice.
Dysregulation of KRT19, TIMP1, and CLDN1 gene expression is associated with thyroid cancer.
Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.
Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squam…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901
Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ